BrainCool AB (publ) - Exercise period for BrainCool's warrants, BRAIN TO 3, 2019-2022, August 24 – September 7, 2020
BRAINCOOL – Många bollar i luften
Handelsstopp i Braincool upphävs
Organization - BrainCool | World-class medical cooling systems
BrainCool aktie (BRAIN) | Alla nyheter, analys, riktkurs… - Börskollen
BrainCool's CEO on the listing announcement from Nasdaq - BioStock
Post - BrainCool | World-class medical cooling systems
BrainCool AB (publ) | LinkedIn
Veckans Aktie - BrainCool » Finanstid
BrainCool AB completes recruitment in trial f | EurekAlert!
BrainCool AB (publ) investerar tre mkr i PolarCool genom kvittning av fordran
Braincool på väg från Spotlight till First North
Market Notice 163/22 – Information regarding the rights issue from BrainCool AB
Post - BrainCool | World-class medical cooling systems
BrainCool AB (publ): Annual audit conducted by TÜV SÜD
BioStock Life Science Spring Summit 2022 | BrainCool - YouTube
BrainCool on the benefits of uplisting to Nasdaq First North - BioStock
BrainCool Seeks De Novo For Device That Prevents Oral Mucositis In Cancer Patients :: Medtech Insight
BrainCool AB (publ) has established direct sales operations in USA
Braincool AB | Aktiespararna
MFN.se > BrainCool > BrainCool AB (publ): BrainCool offentliggör bolagsbeskrivning inför notering på Nasdaq First North Growth Market
Braincool handelsstoppad - Dagens Börs
Organization - BrainCool | World-class medical cooling systems
Trading Direkt analyserar bolagen på Spotlight 2018-12-20: BrainCool & MenuCard - YouTube
BrainCool's IQool™ system aligns with New Ame | EurekAlert!
